Erik R. Sampson
Legacy Health(US)scPharmaceuticals (United States)(US)
Publications by Year
Research Areas
Osteoarthritis Treatment and Mechanisms, TGF-β signaling in diseases, Knee injuries and reconstruction techniques, Prostate Cancer Treatment and Research, Hormonal and reproductive studies
Most-Cited Works
- → MMP13 is a critical target gene during the progression of osteoarthritis(2013)503 cited
- → Teriparatide as a Chondroregenerative Therapy for Injury-Induced Osteoarthritis(2011)173 cited
- → Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype(2008)170 cited
- → High-fat diet accelerates progression of osteoarthritis after meniscal/ligamentous injury(2011)126 cited
- → Induction of an osteoarthritis‐like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice(2008)120 cited
- → Conditional activation of β‐catenin signaling in mice leads to severe defects in intervertebral disc tissue(2012)98 cited
- → Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer(2004)96 cited
- → Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis(2008)68 cited
- → Smurf2 induces degradation of GSK-3β and upregulates β-catenin in chondrocytes: A potential mechanism for Smurf2-induced degeneration of articular cartilage(2009)67 cited
- → Suppression of Androgen Receptor Transactivation by Pyk2 via Interaction and Phosphorylation of the ARA55 Coregulator(2002)54 cited